The U.S., Costa Rica, El Salvador, Guatemala, Honduras and Nicaragua signed the U.S.-Central American Free Trade Agreement ("CAFTA") last week. The agreement would extend patent rights for pharmaceuticals in the Central American countries.

« Revision of Power of Attorney and Assignment Practice | Main | Patent Video »
Occasional guest posts by IP practitioners and academics


Recent Comments